Lucid Diagnostics Strengthens And Expands Market Access And Direct Contracting Efforts; Shaun M. O'Neil Promoted To Lucid's President And COO
Portfolio Pulse from Benzinga Newsdesk
Lucid Diagnostics Inc. (LUCD) has expanded its executive team by hiring Natalie S. Carfora as VP, Market Access, and James M. Fricchione as VP, Employer Markets to support market access and direct contracting efforts. Shaun M. O'Neil has been promoted to President and COO. These moves aim to drive EsoGuard payor coverage and secure direct contracts, which are vital for Lucid's revenue growth. Lucid is a majority-owned subsidiary of PAVmed Inc. (PAVM).
November 16, 2023 | 2:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lucid Diagnostics has strengthened its executive team, which could positively impact its market access and contracting efforts, potentially leading to increased revenue from EsoGuard coverage.
The hiring of experienced executives in market access and employer markets, along with the promotion of Shaun M. O'Neil, indicates a strategic move to enhance Lucid's business operations and revenue potential. This could be viewed positively by investors, as it suggests a commitment to expanding EsoGuard's market presence and improving financial performance.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
As the majority owner of Lucid Diagnostics, PAVmed Inc. may see indirect benefits from Lucid's strengthened executive team and improved market access efforts for EsoGuard.
PAVmed's position as the majority owner of Lucid Diagnostics suggests that improvements in Lucid's business operations and market access strategies could have a positive, albeit indirect, impact on PAVmed's financial outlook and stock performance.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70